June 9 : Privately held Element Biosciences said on Tuesday it had raised funds in an upsized Series E round, including $175 million from longtime investor Samsung Electronics, to expand commercialization of its genetic testing and research products. The San Diego-based company did not disclose the total size of the round or its valuation. It also did not name the other investors. Element said the financing would support commercialization of its sequencing products, such as AVITI and VITARI, as